Mononuclear phagocytes orchestrate prolyl hydroxylase inhibition-mediated renoprotection in chronic tubulointerstitial nephritis.

[1]  Zhanjun Jia,et al.  Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury. , 2018, Clinical science.

[2]  G. Gobe,et al.  Adenine‐induced chronic kidney disease in rats , 2018, Nephrology.

[3]  Mervyn Singer,et al.  Critical illness and flat batteries , 2017, Critical Care.

[4]  P. Maxwell,et al.  Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor , 2017, Kidney international.

[5]  Felix Eichinger,et al.  Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts , 2017, Scientific Reports.

[6]  Tetsuhiro Tanaka,et al.  Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease. , 2017, Kidney international.

[7]  R. Wenger,et al.  Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation , 2017, Nature Communications.

[8]  Prabhleen Singh,et al.  Renal Oxygenation in the Pathophysiology of Chronic Kidney Disease , 2017, Front. Physiol..

[9]  H. Anders,et al.  Crystal nephropathies: mechanisms of crystal-induced kidney injury , 2017, Nature Reviews Nephrology.

[10]  P. Tsao,et al.  Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease. , 2017, Kidney international.

[11]  A. Mortellaro,et al.  C5a Regulates IL-1β Production and Leukocyte Recruitment in a Murine Model of Monosodium Urate Crystal-Induced Peritonitis , 2017, Front. Pharmacol..

[12]  U. Thorsteinsdóttir,et al.  Quantitative UPLC-MS/MS assay of urinary 2,8-dihydroxyadenine for diagnosis and management of adenine phosphoribosyltransferase deficiency. , 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  T. Drüeke,et al.  HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease. , 2016, Kidney international.

[14]  K. Tozawa,et al.  M1/M2-macrophage phenotypes regulate renal calcium oxalate crystal development , 2016, Scientific Reports.

[15]  P. Boor,et al.  An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice. , 2016, Kidney international.

[16]  S. Hemmerich,et al.  Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  B. Gopalan,et al.  Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity , 2016, Proceedings of the National Academy of Sciences.

[18]  P. Boor,et al.  CD103+ Kidney Dendritic Cells Protect against Crescentic GN by Maintaining IL-10-Producing Regulatory T Cells. , 2016, Journal of the American Society of Nephrology : JASN.

[19]  K. Eckardt,et al.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond , 2016, Nature Reviews Nephrology.

[20]  M. Weyand,et al.  Prolyl-hydroxylase inhibitor activating hypoxia-inducible transcription factors reduce levels of transplant arteriosclerosis in a murine aortic allograft model. , 2016, Interactive cardiovascular and thoracic surgery.

[21]  H. Scholz,et al.  Hypoxia inhibits nephrogenesis through paracrine Vegfa despite the ability to enhance tubulogenesis. , 2015, Kidney international.

[22]  C. Kurts,et al.  Dendritic Cells and Macrophages: Sentinels in the Kidney. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[23]  Yanjun Dong,et al.  CX3CL1–CX3CR1 Interaction Increases the Population of Ly6C−CX3CR1hi Macrophages Contributing to Unilateral Ureteral Obstruction–Induced Fibrosis , 2015, The Journal of Immunology.

[24]  G. Schley,et al.  Pre- and post-conditional inhibition of prolyl-4-hydroxylase domain enzymes protects the heart from an ischemic insult , 2015, Pflügers Archiv - European Journal of Physiology.

[25]  S. Colgan,et al.  Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases , 2014, Nature Reviews Drug Discovery.

[26]  K. Tozawa,et al.  Colony-stimulating factor-1 signaling suppresses renal crystal formation. , 2014, Journal of the American Society of Nephrology : JASN.

[27]  Vinícius Andrade-Oliveira,et al.  Macrophage Trafficking as Key Mediator of Adenine-Induced Kidney Injury , 2014, Mediators of inflammation.

[28]  R. Harris,et al.  Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury. , 2014, The Journal of clinical investigation.

[29]  C. Bogdan,et al.  Electroporation of siRNA into mouse bone marrow-derived macrophages and dendritic cells. , 2014, Methods in molecular biology.

[30]  R. Mrowka,et al.  Tubular von Hippel-Lindau knockout protects against rhabdomyolysis-induced AKI. , 2013, Journal of the American Society of Nephrology : JASN.

[31]  H. Anders,et al.  The immune system and kidney disease: basic concepts and clinical implications , 2013, Nature Reviews Immunology.

[32]  N. Câmara,et al.  CALL FOR PAPERS Chronic Kidney Disease and Fibrosis NF- B activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy , 2013 .

[33]  H. Neumayer,et al.  Action of hypoxia‐inducible factor in liver and kidney from mice with Pax8‐rtTA‐based deletion of von Hippel‐Lindau protein , 2013, Acta physiologica.

[34]  M. Nangaku,et al.  Frontiers in Research Review: Kidney Oxygenation in Health and Disease Regulation of hypoxia-inducible factor in kidney disease , 2013 .

[35]  G. Schley,et al.  Selective stabilization of HIF-1α in renal tubular cells by 2-oxoglutarate analogues. , 2012, The American journal of pathology.

[36]  M. Daudon,et al.  Adenine phosphoribosyltransferase deficiency. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[37]  N. Van Rooijen,et al.  Depletion and reconstitution of macrophages in mice. , 2012, Journal of visualized experiments : JoVE.

[38]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[39]  S. Rivella,et al.  Myeloid Cell-Derived Hypoxia-Inducible Factor Attenuates Inflammation in Unilateral Ureteral Obstruction-Induced Kidney Injury , 2012, The Journal of Immunology.

[40]  R. Peyronnet,et al.  Mechanoprotection by Polycystins Against Apoptosis is Mediated Through the Opening of Stretch‐Activated K2P Channels , 2012, Cell reports.

[41]  G. Schley,et al.  The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  T. Winkler,et al.  Renal Tubular HIF-2α Expression Requires VHL Inactivation and Causes Fibrosis and Cysts , 2012, PloS one.

[43]  N. Câmara,et al.  Pivotal Role of Toll-Like Receptors 2 and 4, Its Adaptor Molecule MyD88, and Inflammasome Complex in Experimental Tubule-Interstitial Nephritis , 2011, PloS one.

[44]  G. Schley,et al.  Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury. , 2011, Journal of the American Society of Nephrology : JASN.

[45]  Annely Enke,et al.  Tubular deficiency of von Hippel-Lindau attenuates renal disease progression in anti-GBM glomerulonephritis. , 2011, The American journal of pathology.

[46]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[47]  Glenda C Gobe,et al.  Biomarkers in chronic kidney disease: a review. , 2011, Kidney International.

[48]  S. Rosen,et al.  Hypoxia-inducible factors and the prevention of acute organ injury , 2011, Critical care.

[49]  P. Ratcliffe,et al.  Differential Sensitivity of Hypoxia Inducible Factor Hydroxylation Sites to Hypoxia and Hydroxylase Inhibitors* , 2011, The Journal of Biological Chemistry.

[50]  Sik Lee,et al.  Distinct macrophage phenotypes contribute to kidney injury and repair. , 2011, Journal of the American Society of Nephrology : JASN.

[51]  C. Schofield,et al.  Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. , 2011, Trends in biochemical sciences.

[52]  K. Tozawa,et al.  Renal macrophage migration and crystal phagocytosis via inflammatory‐related gene expression during kidney stone formation and elimination in mice: Detection by association analysis of stone‐related gene expression and microstructural observation , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[53]  P. Vandenabeele,et al.  Hydroxylase Inhibition Abrogates TNF-α–Induced Intestinal Epithelial Damage by Hypoxia-Inducible Factor-1–Dependent Repression of FADD , 2010, The Journal of Immunology.

[54]  A. Hoffmann,et al.  Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. , 2010, Genes & development.

[55]  W. B. Reeves,et al.  Renal dendritic cells ameliorate nephrotoxic acute kidney injury. , 2010, Journal of the American Society of Nephrology : JASN.

[56]  J. Bonventre,et al.  HIF in kidney disease and development. , 2009, Journal of the American Society of Nephrology.

[57]  W. Kaelin,et al.  A Feedback Loop Involving the Phd3 Prolyl Hydroxylase Tunes the Mammalian Hypoxic Response In Vivo , 2009, Molecular and Cellular Biology.

[58]  M. Simon,et al.  Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis. , 2009, Blood.

[59]  B. Buchholz,et al.  HIF-prolyl hydroxylases in the rat kidney: physiologic expression patterns and regulation in acute kidney injury. , 2009, The American journal of pathology.

[60]  T. Sugaya,et al.  Cardiovascular , Pulmonary and Renal Pathology Urinary L-Type Fatty Acid-Binding Protein Can Reflect Renal Tubulointerstitial Injury , 2010 .

[61]  M. Rudnicki,et al.  Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease , 2009, Laboratory Investigation.

[62]  P. Carmeliet,et al.  Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease , 2009, Nature Reviews Drug Discovery.

[63]  H. Ozaki,et al.  Progressive renal dysfunction and macrophage infiltration in interstitial fibrosis in an adenine-induced tubulointerstitial nephritis mouse model , 2009, Histochemistry and Cell Biology.

[64]  S. Dauwe,et al.  An active renal crystal clearance mechanism in rat and man. , 2009, Kidney international.

[65]  C. Bogdan,et al.  Generation, culture and flow-cytometric characterization of primary mouse macrophages. , 2009, Methods in molecular biology.

[66]  K. Kimura,et al.  Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. , 2008, American journal of physiology. Renal physiology.

[67]  W. Kaelin,et al.  Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.

[68]  J Concato,et al.  Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. , 2008, Kidney international.

[69]  W. Kaelin,et al.  Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. , 2008, Blood.

[70]  S. Colgan,et al.  Mucosal protection by hypoxia‐inducible factor (HIF) prolyl hydroxylase inhibition , 2008 .

[71]  Hyoung-Kyu kim,et al.  Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[72]  E. Cummins,et al.  The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. , 2008, Gastroenterology.

[73]  K. Kimura,et al.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. , 2007, The Journal of clinical investigation.

[74]  T. Sato,et al.  Tubular changes in obstructed kidney of adult mice evaluated using immunohistochemistry for segment-specific marker. , 2007, Histology and histopathology.

[75]  R. Johnson,et al.  Acute postnatal ablation of Hif-2α results in anemia , 2007, Proceedings of the National Academy of Sciences.

[76]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[77]  P. Jaakkola,et al.  Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. , 2004, The Biochemical journal.

[78]  K. Matsushima,et al.  Blockade of CCR2 ameliorates progressive fibrosis in kidney. , 2004, The American journal of pathology.

[79]  M. Wood,et al.  Regulation of HIF prolyl hydroxylases by hypoxia‐inducible factors , 2004, Journal of cellular biochemistry.

[80]  W. Reith,et al.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.

[81]  S. Kiley,et al.  Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. , 2003, Kidney international.

[82]  P. Igarashi,et al.  Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. , 2002, Journal of the American Society of Nephrology : JASN.

[83]  Kai-Uwe Eckardt,et al.  Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. , 2002, Journal of the American Society of Nephrology : JASN.

[84]  Michael I. Wilson,et al.  C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.

[85]  M. Kashgarian,et al.  The clinical spectrum of tubulointerstitial nephritis. , 1998, Kidney international.

[86]  Jessica Lo,et al.  HIF‐1α is required for solid tumor formation and embryonic vascularization , 1998 .

[87]  G. Melillo,et al.  Functional Requirement of the Hypoxia-responsive Element in the Activation of the Inducible Nitric Oxide Synthase Promoter by the Iron Chelator Desferrioxamine* , 1997, The Journal of Biological Chemistry.

[88]  B. Ebert,et al.  Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences (*) , 1995, The Journal of Biological Chemistry.

[89]  M. Brezis,et al.  Hypoxia of the renal medulla--its implications for disease. , 1995, The New England journal of medicine.

[90]  G. Semenza,et al.  Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. , 1994, The Journal of biological chemistry.

[91]  S. Abramson,et al.  Activation of the alternative pathway of complement by monosodium urate crystals. , 1983, Clinical immunology and immunopathology.

[92]  W. O’Brien,et al.  Modified assay for determination of hydroxyproline in a tissue hydrolyzate. , 1980, Clinica chimica acta; international journal of clinical chemistry.